Phaarmasia Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 306122, "name": "Phaarmasia", "stock_name": "Phaarmasia", "full_name": "Phaarmasia Ltd", "name_url": "stocks-analysis/phaarmasia", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "113.80", "chg": 1.8, "chgp": "1.61%", "dir": 1, "prev_price": "112.00", "mcapval": "76.00 Cr", "mcap": "Micro Cap", "scripcode": 523620, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE486I01016", "curr_date": "Apr 17", "curr_time": "", "bse_nse_vol": "150 ", "exc_status": "Active", "traded_date": "Apr 17, 2026", "traded_date_str": "2026 04 17", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/phaarmasia-306122-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Phaarmasia Ltd Valuation Shifts Signal Renewed Investor Interest Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-valuation-shifts-signal-renewed-investor-interest-amid-sector-challenges-3946412", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PhaarmasiaLtd_valuationdot_3946412.png", "date": "2026-04-15 08:00:42", "description": "Phaarmasia Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, signalling a renewed price appeal for investors. This micro-cap pharmaceutical player’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside other key metrics, suggest a more favourable investment proposition compared to its historical averages and peer group benchmarks." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3944616", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PhaarmasiaLtd_mojoScore_3944616.png", "date": "2026-04-13 10:10:32", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 13 April 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3930154", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PhaarmasiaLtd_mojoScore_3930154.png", "date": "2026-04-02 10:10:29", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 02 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3893204", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PhaarmasiaLtd_mojoScore_3893204.png", "date": "2026-03-16 10:10:31", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 March 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3873051", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PhaarmasiaLtd_mojoScore_3873051.png", "date": "2026-03-05 10:10:53", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing." }, { "title": "Phaarmasia Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-is-rated-hold-by-marketsmojo-3849255", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_mojoScore_3849255.png", "date": "2026-02-21 10:10:31", "description": "Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Phaarmasia Ltd Gains 11.55%: Key Valuation and Technical Upgrades Drive Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-gains-1155-key-valuation-and-technical-upgrades-drive-rally-3840701", "imagepath": "", "date": "2026-02-15 09:00:58", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>09 Feb:</strong> Stock opens at ₹108.81 following upgrade to Hold</p>\n <p><strong>10 Feb:</strong> Valuation shifts signal renewed price attractiveness</p>\n <p><strong>12 Feb:</strong> Minor correction amid broader market weakness</p>\n <p><strong>13 Feb:</strong> Week closes at ₹115.60, up 11.55% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹103.63</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹115.60</div><div cl..." }, { "title": "Phaarmasia Ltd Upgraded to Hold as Valuation and Technicals Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/phaarmasia-ltd-upgraded-to-hold-as-valuation-and-technicals-improve-3829845", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_mojoScore_3829845.png", "date": "2026-02-10 08:05:07", "description": "Phaarmasia Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across technical indicators and valuation metrics. The company’s recent financial performance, coupled with a bullish technical outlook and attractive valuation compared to peers, has prompted this reassessment by analysts as of 09 Feb 2026." }, { "title": "Phaarmasia Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/phaarmasia-ltd-valuation-shifts-signal-renewed-price-attractiveness-3829521", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/PhaarmasiaLtd_valuationdot_3829521.png", "date": "2026-02-10 08:00:42", "description": "Phaarmasia Ltd has witnessed a significant re-rating in its valuation parameters, transitioning from a previously expensive profile to one now deemed attractive by market standards. This shift is underscored by a notable improvement in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector." } ], "total": 720, "sid": "306122", "stock_news_url": "https://www.marketsmojo.com/news/phaarmasia-306122" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "17-Apr-2026", "details": "Certificate under Reg 74(5) of SEBI(Depositories and Participants) Reg 2018 for the quarter and Year Ended 31st march 2026.", "source": "BSE" }, { "caption": "Announcement Under Reg-30_Clarification", "datetime": "15-Apr-2026", "details": "The Exchange has Sought Clarification on Price Movement with reference to Significant Movement in Price in Order to Ensure that Investors have Latest Information about the company So that the interest of the investors are Safeguarded.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address", "datetime": "15-Apr-2026", "details": "Intimation of Change in the Registered Office of the Company within the Local Limits of City", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

09 Feb: Stock opens at ₹108.81 following upgrade to Hold

10 Feb: Valuation shifts signal renewed price attractiveness

12 Feb: Minor correction amid broader market weakness

13 Feb: Week closes at ₹115.60, up 11.55% for the week

Read full news article

Phaarmasia Ltd Upgraded to Hold as Valuation and Technicals Improve

2026-02-10 08:05:07

Phaarmasia Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements across technical indicators and valuation metrics. The company’s recent financial performance, coupled with a bullish technical outlook and attractive valuation compared to peers, has prompted this reassessment by analysts as of 09 Feb 2026.

Read full news article

Phaarmasia Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-02-10 08:00:42

Phaarmasia Ltd has witnessed a significant re-rating in its valuation parameters, transitioning from a previously expensive profile to one now deemed attractive by market standards. This shift is underscored by a notable improvement in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article